PureTech Health (PRTC) Receivables - Other (2019 - 2022)

PureTech Health (PRTC) reported Receivables - Other of $450000.0 for Q4 2022, up 8.43% year-over-year from $415000.0 in Q4 2021, and up 8.43% on a QoQ basis from $415000.0 in Q4 2021.

PureTech Health (PRTC) has 4 years of Receivables - Other data on file, last reported at $450000.0 in Q4 2022.

  • Quarterly Receivables - Other rose 8.43% year-over-year to $450000.0 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $450000.0 (up 8.43% YoY) and the FY2022 annual result came in at $450000.0, up 8.43% from the prior year.
  • Receivables - Other rose to $450000.0 in Q4 2022 per PRTC's latest filing, from $415000.0 in the prior quarter.
  • Across five years, Receivables - Other topped out at $450000.0 in Q4 2022 and bottomed at $350000.0 in Q4 2019.
  • The 4-year median for Receivables - Other is $398000.0 (2020), against an average of $399000.0.
  • The widest annual swing landed in 2021, when Receivables - Other grew 8.92%; it then grew 8.43% in 2022.
  • Tracing PRTC's Receivables - Other over 4 years: stood at $350000.0 in 2019, then advanced by 8.86% to $381000.0 in 2020, then rose by 8.92% to $415000.0 in 2021, then gained by 8.43% to $450000.0 in 2022.
  • Per Business Quant, the three latest PRTC Receivables - Other figures stand at $450000.0 (Q4 2022), $415000.0 (Q4 2021), and $381000.0 (Q4 2020).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn -
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn -
5 Akari Therapeutics 605.66 Bn 605.66 Bn -
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn
8 Evaxion A 65.12 Bn 65.10 Bn -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn
10 PureTech Health 86.36 Mn -190.94 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2022 450,000.00
Dec 31, 2022 450,000.00
Dec 31, 2021 415,000.00
Dec 31, 2021 415,000.00
Dec 31, 2020 381,000.00
Dec 31, 2020 381,000.00
Dec 31, 2019 350,000.00
Dec 31, 2019 350,000.00